Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

2

Revenue 2017

Revlimid

The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Revlimid was produced by Celgene.

Celgene hopes for second time lucky for ozanimod FDA filing

Celgene hopes for second time lucky for ozanimod FDA filing One of six key drugs for BMS-Celgene merger

Janssen looks to expand Darzalex in Europe

Janssen looks to expand Darzalex in Europe Regimen reduced risk of disease progression or death by 44%. Janssen is looking to broaden the use of its multiple myeloma blockbuster Darzalex, this time combining it with Celgene’s Revlimid ... Those patients were directly compared to a group taking

NICE partially clears Darzalex combo in blood cancer

NICE partially clears Darzalex combo in blood cancer Notably, 29% of those in one trial arm used Celgene’s Revlimid as their first-line treatment; where as only 12% in the other group used Darzalex. ... Clinical experts stated that there was no evidence to suggest that Revlimid modifies the effect of

BMS trades blows with investor on Celgene deal merits

BMS trades blows with investor on Celgene deal merits The activist investors claim that BMS is buying a company with a massive patent cliff – principally blood cancer blockbuster Revlimid (lenalidomide) – which they say will requite Celgene to replace 60% of

FDA begins speedy review of Celgene’s Revlimid combo in lymphoma

FDA begins speedy review of Celgene’s Revlimid combo in lymphoma It also met the secondary endpoint of overall survival, with only 16 death events reported in the Revlimid combo group versus 26 death events in the comparator arm. ... It's one of five new drugs that Celgene aims to launch through 2020, and the company

[ Previous 5 results ] 1 2 3 4 5 6 7 8 9 10 [ Next 5 results ]

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Fishawack Group of Companies

The Fishawack Group of Companies is one of the largest independent medical communications and medical marketing specialists, with teams in...

Latest intelligence

Five companies 20 for 2020
20 for 2020 – Five pharma companies to watch
As a new decade gets into gear, we take a look at five pharma companies that have a lot riding on 2020...
The growing clinical importance of patient-reported outcomes (PROs)
Traditionally, the success or otherwise of medical treatments has been assessed by mortality or clinical assessments of health. However, patient self-reports of health are increasingly seen as central to the...
Generation Z
The roaring ‘20s and Generation Z
How a new generation will shape pharma comms this decade...

Infographics